FORTIS · Healthcare
Fortis Healthcare Ltd. reported revenue of ₹2,167 cr for April to June 2025, +16.6% on the year and +8.0% on the quarter. It is the highest quarterly revenue in the last 9 quarters on record. Over the last four quarters revenue comes to ₹8,090 cr, +14.0% on the four before.
Operating profit (EBITDA) was ₹491 cr, a margin of 22.7%, +421 bps on the year and +98 bps on the quarter. It is the widest margin of the last 8 quarters (range 16.9% to 22.7%). Operating costs grew +10.6% against revenue growth of +16.6%, so more of each rupee of sales reached operating profit.
Net profit was ₹267 cr, +53.4% on the year and +42.0% on the quarter, with earnings per share of ₹3.45. Profit before other income, one-offs and tax grew 48.1%, so 5 points of the headline growth came from outside the core business. The tax rate of 24% is in line with its recent average. Profit over the last four quarters totals ₹902 cr, +29.8% on the four before.
On earnings per share of ₹11.51 over the last four quarters, the stock at ₹736.50 trades at 64.0 times trailing earnings.
Written from the quarterly statements. The filing read adds the balance sheet and cash flow, the auditor's review, segment results, one-off items line by line and what management said on the call.
No check fired. That is a statement about the checks below, not a verdict on the company.
Could not run on this quarter: Exceptional items that recur, Cash behind the profit, Receivables against sales, Inventory against sales, Borrowing while holding cash, Auditor's review or audit report, IPO money used as stated, Related-party transactions, Exits, postponements, restatements, Promoter pledges and allotments, Earlier promises against delivery, When the results were filed. Most need the filing read (balance sheet, cash flow, auditor, disclosures).
Net profit a year ago, each driver's change, and net profit now. Blue added profit, red took it away.
| Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1,770 cr | ₹1,680 cr | ₹1,786 cr | ₹1,859 cr | ₹1,988 cr | ₹1,928 cr | ₹2,007 cr | ₹2,167 cr | ₹2,331 cr | ₹2,265 cr | ₹2,365 cr | ₹2,545 cr |
| YoY | — | — | — | +12% | +12% | +15% | +12% | +17% | +17% | +17% | +18% | +17% |
| EBITDA margin | 18.6% | 16.9% | 21.3% | 18.5% | 21.9% | 19.5% | 21.7% | 22.7% | 23.9% | 22.3% | 22.5% | 21.1% |
| Other income, % of PBT | 8% | 10% | 6% | 6% | −16% | 17% | −12% | 9% | 12% | −13% | −1% | 8% |
| Exceptional items | — | — | — | — | — | — | — | — | — | — | — | — |
| Tax rate | 21% | 27% | 25% | 24% | 26% | 9% | 21% | 24% | 23% | 26% | 16% | 25% |
| Net profit | ₹184 cr | ₹134 cr | ₹203 cr | ₹174 cr | ₹193 cr | ₹254 cr | ₹188 cr | ₹267 cr | ₹329 cr | ₹197 cr | ₹271 cr | ₹273 cr |
| YoY | — | — | — | +40% | +5% | +90% | −7% | +53% | +70% | −22% | +44% | +2% |
| Core profit YoY | — | — | — | +34% | +41% | +41% | +5% | +48% | +24% | +29% | +23% | +5% |
| EPS | ₹2.30 | ₹1.78 | ₹2.37 | ₹2.20 | ₹2.34 | ₹3.28 | ₹2.44 | ₹3.45 | ₹4.26 | ₹2.57 | ₹3.52 | ₹3.53 |
| Flags | · | · | · | ✓ | ✓ | 2 | 1 | ✓ | 1 | 1 | 1 | ✓ |
Each quarter is read with the same rules. Balance-sheet and cash checks run on half-year and annual quarters; filing-read checks run where a read exists.
Fortis Healthcare Ltd. reported revenue of ₹2,167 cr (+16.6% on the year) and net profit of ₹267 cr (+53.4% on the year) for April to June 2025.
Profit before other income, exceptional items and tax moved +48.1% on the year, against +53.4% for reported profit.
None of the 7 checks that could run raised a question.
No. FinMinutes reports what was filed and the questions the numbers raise. It does not recommend buying, selling or holding any security.
Numbers as filed with the exchanges, read by rules. Every flag is a question with its source, not an accusation. FinMinutes is a financial data and analytics platform; nothing here is a recommendation to buy, sell or hold any security. How each check works.